| 000 | 01788 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514191642.0 | ||
| 264 | 0 | _c20040716 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/01.ccm.0000127264.54807.b7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDünser, Martin W | |
| 245 | 0 | 0 |
_aEndocrinologic response to vasopressin infusion in advanced vasodilatory shock. _h[electronic resource] |
| 260 |
_bCritical care medicine _cJun 2004 |
||
| 300 |
_a1266-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xblood |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAldosterone _xblood |
| 650 | 0 | 4 |
_aAngiotensin II _xblood |
| 650 | 0 | 4 |
_aArginine Vasopressin _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xblood |
| 650 | 0 | 4 |
_aEndocrine Glands _xdrug effects |
| 650 | 0 | 4 | _aEndothelin-1 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNorepinephrine _xadministration & dosage |
| 650 | 0 | 4 |
_aProlactin _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 |
_aShock _xdrug therapy |
| 700 | 1 | _aHasibeder, Walter R | |
| 700 | 1 | _aWenzel, Volker | |
| 700 | 1 | _aSchwarz, Siegfried | |
| 700 | 1 | _aUlmer, Hanno | |
| 700 | 1 | _aKnotzer, Hans | |
| 700 | 1 | _aPajk, Werner | |
| 700 | 1 | _aFriesenecker, Barbara E | |
| 700 | 1 | _aMayr, Andreas J | |
| 773 | 0 |
_tCritical care medicine _gvol. 32 _gno. 6 _gp. 1266-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ccm.0000127264.54807.b7 _zAvailable from publisher's website |
| 999 |
_c14894583 _d14894583 |
||